Back to Newsroom
Back to Newsroom

The Assistance Fund Opens New Program for Idiopathic Hypersomnia

Monday, 28 August 2023 12:00 PM

The Assistance Fund (TAF)

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Idiopathic Hypersomnia

ORLANDO, FL / ACCESSWIRE / August 28, 2023 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with idiopathic hypersomnia. The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to idiopathic hypersomnia, such as copays, health insurance premiums, and incidental medical expenses.

Idiopathic hypersomnia (IH) is a rare condition causing people to have difficulty staying awake during the day.[1] Tiredness may begin at any time during the day and can severely disrupt normal activity. Many people living with IH sleep more than 11 hours a day and still do not feel rested.[2]

"Most people living with idiopathic hypersomnia require treatment to perform the most basic, everyday tasks," said Danielle Vizcaino, President and CEO at The Assistance Fund. "Thanks to our generous donors, TAF's new Idiopathic Hypersomnia Financial Assistance Program will enable people living with this condition to lead healthier and more productive lives."

To learn more or determine eligibility for financial support, visit tafcares.org or call (855) 369-2728 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped nearly 180,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic or rare disease. To learn more about The Assistance Fund or for information on how to donate, please visit tafcares.org.

[1] National Center for Advancing Translational Sciences Genetic and Rare Diseases Information Center, National Institutes of Health, "Idiopathic hypersomnia," https://rarediseases.info.nih.gov/diseases/8737/idiopathic-hypersomnia, accessed May 2023.

[2] Hypersomnia Foundation, "About Idiopathic Hypersomnia," accessed May 2023.

Contact Information

Margaret Figley
Senior Director of Communications
[email protected]

SOURCE: The Assistance Fund (TAF)

.
Topic:
Company Update
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: